Dr. Paul G. Richardson Provides Study Updates on the Phase 3 DETERMINATION Trial for NDMM patients International Myeloma Foundation 17:24 2 years ago 1 543 Далее Скачать
Triplet Therapy Determination Phase 3 Trial | Paul Richardson, MD | ASH 2023 HealthTree Foundation for Multiple Myeloma 2:54 10 months ago 220 Далее Скачать
Current and Future Directions for Novel Therapy for Multiple Myeloma: Paul G. Richardson, MD Dana-Farber Cancer Institute 37:46 2 years ago 1 957 Далее Скачать
Lenalidomide, bortezomib, and dexamethasone ASCT to progress for NDMM: Phase 3 DETERMINATION trial ecancer 9:51 2 years ago 146 Далее Скачать
2024 Mid-Year Myeloma Review with Paul Richardson, MD, Dana Farber Cancer Institute HealthTree Foundation for Multiple Myeloma 1:09:44 1 month ago 523 Далее Скачать
Dr. Richardson on First-In-Human Phase 1 Trial With CC-92480 in R/R Myeloma OncLive 1:36 4 years ago 90 Далее Скачать
Dr. Paul Richardson on novel approaches for treating multiple myeloma | Dana-Farber Cancer Institute Dana-Farber Cancer Institute 35:50 6 years ago 5 228 Далее Скачать
What are new treatment options for newly-diagnosed multiple myeloma patients? Dr. Paul G. Richardson Dana-Farber Cancer Institute 44:05 5 years ago 4 935 Далее Скачать
Update on the LIGHTHOUSE (OP-108) trial VJHemOnc – Video Journal of Hematology & HemOnc 3:07 3 years ago 1 100 Далее Скачать
Dr. Richardson on the Next Steps With CC-92480 Research in Relapsed/Refractory Multiple Myeloma OncLive 1:00 4 years ago 57 Далее Скачать
Paul G. Richardson, MD, regarding the updated FORTE trial data in multiple myeloma OBRoncology 3:48 5 years ago 30 Далее Скачать
Dr. Richardson on the Mechanism of Action of CC-92480 in Multiple Myeloma OncLive 1:52 4 years ago 292 Далее Скачать
Myeloma Determination Study | Paul Richardson, MD | IMS 2022 HealthTree Foundation for Multiple Myeloma 7:32 2 years ago 1 302 Далее Скачать
Evaluating Response Rates With CC-92480 Combination in Multiple Myeloma Targeted Oncology 1:42 4 years ago 85 Далее Скачать
Multiple myeloma mid-year progress with Dr. Paul Richardson of Dana Farber HealthTree Foundation for Multiple Myeloma 1:04:18 8 months ago 146 Далее Скачать
New Options To Treat Newly Dx, Relapsed Myeloma — Dr. Paul Richardson | MCRT Webcast July 11 HealthTree Foundation for Multiple Myeloma 11:37 4 years ago 166 Далее Скачать
Mezigdomide Plus Dexamethasone in RRMM: CC-92480-MM-002 Trial Results| Paul Richardson, MD |ASH 2023 HealthTree Foundation for Multiple Myeloma 2:47 10 months ago 185 Далее Скачать
Results of the Phase 2 IFM 2018-04 Study in High-Risk, Transplant-Eligible NDMM Patients International Myeloma Foundation 5:54 2 years ago 450 Далее Скачать
ATLAS: Phase 3 Trial Comparing Post-ASCT treatment with KRd vs Post-ASCT with R maintenance International Myeloma Foundation 11:47 2 years ago 301 Далее Скачать
New Directions in Treating Multiple Myeloma in the Era of Novel Agents Dana-Farber Cancer Institute 47:17 3 years ago 2 120 Далее Скачать
